In the United Kingdom, preliminary data indicate that infections among healthcare workers who received their first dose of Pfizer vaccine have dropped by about 70%.
Public Health England (PHE) has determined that Pfizer’s first dose provides a high level of protection against infection and symptomatic illness.
“Overall, we are seeing a really significant impact on reducing infections, both asymptomatic and symptomatic,” said Susan Hopkins, Director of Strategic Response at PHE.
PHE’s chief of immunization, Mary Ramsay, called the data “compelling evidence that the Pfizer vaccine prevents people from becoming infected and also protects patients from hospitalization and death.”
PHE’s findings are based on the results of two separate studies: the first in healthcare professionals and the second in older adults aged 80 and over.
According to the findings of the Public Health Service, the first dose of Pfizer vaccine against symptomatic COVID-19 disease is 57%, the second dose increases protection to more than 85%.
“Hospital admissions and mortality rates are falling across all age groups, but the oldest age groups are seeing the fastest decline since peaking in mid-January,” the Service said in a statement.
At the same time, PHE noted that the drug also provides protection against the “British strain” of the coronavirus.
#Vaccination #Britain #Pfizer #vaccine #highly #effective